These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7185771)

  • 1. Phospholipid liposomes in depression: a double-blind study versus placebo.
    Casacchia M; Meco G; Pirro R; Di Cesare E; Allegro A; Cusimano G; Marola W
    Int Pharmacopsychiatry; 1982; 17(4):274-9. PubMed ID: 7185771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial.
    Sallee FR; Vrindavanam NS; Deas-Nesmith D; Carson SW; Sethuraman G
    Am J Psychiatry; 1997 May; 154(5):668-73. PubMed ID: 9137123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.
    Petracca G; Tesón A; Chemerinski E; Leiguarda R; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):270-5. PubMed ID: 8854297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ; Moritz E; Hellstern K; Malanowski H
    Acta Psychiatr Scand Suppl; 1990; 360():46-7. PubMed ID: 2248069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine.
    Nielsen NP; Cesana B; Zizolfi S; Ascalone V; Priore P; Morselli PL
    Acta Psychiatr Scand; 1990 Nov; 82(5):366-71. PubMed ID: 2281807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute antidepressant effect following pulse loading with intravenous and oral clomipramine.
    Pollock BG; Perel JM; Nathan RS; Kupfer DJ
    Arch Gen Psychiatry; 1989 Jan; 46(1):29-35. PubMed ID: 2642691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
    Samuelian JC; Hackett D
    J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of sleep deprivation and clomipramine in endogenous depression.
    Elsenga S; van den Hoofdakker RH
    J Psychiatr Res; 1982-1983; 17(4):361-74. PubMed ID: 7187779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
    Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
    [No Abstract]   [Full Text] [Related]  

  • 12. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypothalamic phospholipid liposomes in the treatment of the climacteric syndrome].
    Jasonni VM; Palareti A; Bulletti C; Fuschini G; Naldi S; Ricciardelli E
    Minerva Ginecol; 1989 Apr; 41(4):187-93. PubMed ID: 2797500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypothalamic phospholipid liposomes. A drug for the treatment of anxiety-depressive syndromes in internal medicine].
    Licata G
    Recenti Prog Med; 1984 Dec; 75(12):1076-80. PubMed ID: 6528083
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind trial with oral versus intravenous clomipramine in primary depression.
    Faravelli C; Broadhurst AD; Ambonetti A; Ballerini A; De Biase L; La Malfa G; Das M
    Biol Psychiatry; 1983 Jun; 18(6):695-706. PubMed ID: 6871303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
    J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of clomipramine and doxepin in neurotic depression.
    Kornhaber A; Horwitz IM
    J Clin Psychiatry; 1984 Aug; 45(8):337-41. PubMed ID: 6378895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
    Gagiano CA; Müller PG; Fourie J; Le Roux JF
    Acta Psychiatr Scand Suppl; 1989; 350():130-1. PubMed ID: 2530765
    [No Abstract]   [Full Text] [Related]  

  • 19. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
    Thorén P; Asberg M; Cronholm B; Jörnestedt L; Träskman L
    Arch Gen Psychiatry; 1980 Nov; 37(11):1281-5. PubMed ID: 7436690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled study.
    Lemoine P; Boulenger JP; Caillard V; Tanne N; Bonnet D
    Pharmacopsychiatry; 1991 Sep; 24(5):175-9. PubMed ID: 1775523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.